Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study
ObjectivesInflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD.MethodsIn a nationwide population-bas...
Saved in:
Published in | Inflammatory bowel diseases Vol. 22; no. 5; pp. 1049 - 1055 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford University Press
01.05.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ObjectivesInflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD.MethodsIn a nationwide population-based cohort of 23.22 million insured residents of Taiwan aged ≥ 20 years, we compared people diagnosed with IBD during 2000 to 2011 (n = 8373) with IBD-free individuals. Patients with PD were identified in the National Health Insurance Research Database. Using univariable and multivariable Cox proportion hazard regression models, we estimated the adjusted hazard ratio (aHR) for PD with a 95% confidence interval (CI) with adjustment for age, sex, and comorbidities.ResultsIn the cohort, IBD was associated with an increased incidence of PD (crude hazard ratio = 1.43, 95% CI = 1.15–1.79). The risk was highest among individuals with Crohn's disease (aHR = 1.40, 95% CI = 1.11–1.77). In the multivariable model, the risk of PD was increased for men (aHR = 1.28, 95% CI = 1.05–1.56) and higher for patients with hypertension (aHR = 1.72, 95% CI = 1.33–2.24), coronary artery disease (aHR = 1.31, 95% CI = 1.04–1.66), or depression (aHR = 2.51, 95% CI = 1.82–3.46).ConclusionsWe suggest that IBD is associated with an increased risk of PD. Patients with IBD should be aware of the potential risk for PD development. |
---|---|
AbstractList | Inflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD.OBJECTIVESInflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD.In a nationwide population-based cohort of 23.22 million insured residents of Taiwan aged ≥ 20 years, we compared people diagnosed with IBD during 2000 to 2011 (n = 8373) with IBD-free individuals. Patients with PD were identified in the National Health Insurance Research Database. Using univariable and multivariable Cox proportion hazard regression models, we estimated the adjusted hazard ratio (aHR) for PD with a 95% confidence interval (CI) with adjustment for age, sex, and comorbidities.METHODSIn a nationwide population-based cohort of 23.22 million insured residents of Taiwan aged ≥ 20 years, we compared people diagnosed with IBD during 2000 to 2011 (n = 8373) with IBD-free individuals. Patients with PD were identified in the National Health Insurance Research Database. Using univariable and multivariable Cox proportion hazard regression models, we estimated the adjusted hazard ratio (aHR) for PD with a 95% confidence interval (CI) with adjustment for age, sex, and comorbidities.In the cohort, IBD was associated with an increased incidence of PD (crude hazard ratio = 1.43, 95% CI = 1.15-1.79). The risk was highest among individuals with Crohn's disease (aHR = 1.40, 95% CI = 1.11-1.77). In the multivariable model, the risk of PD was increased for men (aHR = 1.28, 95% CI = 1.05-1.56) and higher for patients with hypertension (aHR = 1.72, 95% CI = 1.33-2.24), coronary artery disease (aHR = 1.31, 95% CI = 1.04-1.66), or depression (aHR = 2.51, 95% CI = 1.82-3.46).RESULTSIn the cohort, IBD was associated with an increased incidence of PD (crude hazard ratio = 1.43, 95% CI = 1.15-1.79). The risk was highest among individuals with Crohn's disease (aHR = 1.40, 95% CI = 1.11-1.77). In the multivariable model, the risk of PD was increased for men (aHR = 1.28, 95% CI = 1.05-1.56) and higher for patients with hypertension (aHR = 1.72, 95% CI = 1.33-2.24), coronary artery disease (aHR = 1.31, 95% CI = 1.04-1.66), or depression (aHR = 2.51, 95% CI = 1.82-3.46).We suggest that IBD is associated with an increased risk of PD. Patients with IBD should be aware of the potential risk for PD development.CONCLUSIONSWe suggest that IBD is associated with an increased risk of PD. Patients with IBD should be aware of the potential risk for PD development. Objectives: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD. Methods: In a nationwide population-based cohort of 23.22 million insured residents of Taiwan aged > or = 20 years, we compared people diagnosed with IBD during 2000 to 2011 (n = 8373) with IBD-free individuals. Patients with PD were identified in the National Health Insurance Research Database. Using univariable and multivariable Cox proportion hazard regression models, we estimated the adjusted hazard ratio (aHR) for PD with a 95% confidence interval (CI) with adjustment for age, sex, and comorbidities. Results: In the cohort, IBD was associated with an increased incidence of PD (crude hazard ratio = 1.43, 95% CI = 1.15-1.79). The risk was highest among individuals with Crohn's disease (aHR = 1.40, 95% CI = 1.11-1.77). In the multivariable model, the risk of PD was increased for men (aHR = 1.28, 95% CI = 1.05-1.56) and higher for patients with hypertension (aHR = 1.72, 95% CI = 1.33-2.24), coronary artery disease (aHR = 1.31, 95% CI = 1.04-1.66), or depression (aHR = 2.51, 95% CI = 1.82-3.46). Conclusions: We suggest that IBD is associated with an increased risk of PD. Patients with IBD should be aware of the potential risk for PD development. ObjectivesInflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD.MethodsIn a nationwide population-based cohort of 23.22 million insured residents of Taiwan aged ≥ 20 years, we compared people diagnosed with IBD during 2000 to 2011 (n = 8373) with IBD-free individuals. Patients with PD were identified in the National Health Insurance Research Database. Using univariable and multivariable Cox proportion hazard regression models, we estimated the adjusted hazard ratio (aHR) for PD with a 95% confidence interval (CI) with adjustment for age, sex, and comorbidities.ResultsIn the cohort, IBD was associated with an increased incidence of PD (crude hazard ratio = 1.43, 95% CI = 1.15–1.79). The risk was highest among individuals with Crohn's disease (aHR = 1.40, 95% CI = 1.11–1.77). In the multivariable model, the risk of PD was increased for men (aHR = 1.28, 95% CI = 1.05–1.56) and higher for patients with hypertension (aHR = 1.72, 95% CI = 1.33–2.24), coronary artery disease (aHR = 1.31, 95% CI = 1.04–1.66), or depression (aHR = 2.51, 95% CI = 1.82–3.46).ConclusionsWe suggest that IBD is associated with an increased risk of PD. Patients with IBD should be aware of the potential risk for PD development. Inflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of Parkinson's disease (PD). This study examined the effects of IBD on the development of PD. In a nationwide population-based cohort of 23.22 million insured residents of Taiwan aged ≥ 20 years, we compared people diagnosed with IBD during 2000 to 2011 (n = 8373) with IBD-free individuals. Patients with PD were identified in the National Health Insurance Research Database. Using univariable and multivariable Cox proportion hazard regression models, we estimated the adjusted hazard ratio (aHR) for PD with a 95% confidence interval (CI) with adjustment for age, sex, and comorbidities. In the cohort, IBD was associated with an increased incidence of PD (crude hazard ratio = 1.43, 95% CI = 1.15-1.79). The risk was highest among individuals with Crohn's disease (aHR = 1.40, 95% CI = 1.11-1.77). In the multivariable model, the risk of PD was increased for men (aHR = 1.28, 95% CI = 1.05-1.56) and higher for patients with hypertension (aHR = 1.72, 95% CI = 1.33-2.24), coronary artery disease (aHR = 1.31, 95% CI = 1.04-1.66), or depression (aHR = 2.51, 95% CI = 1.82-3.46). We suggest that IBD is associated with an increased risk of PD. Patients with IBD should be aware of the potential risk for PD development. |
Author | Lin, Jung-Chun Lin, Chin-Sheng Hsu, Chin-Wang Lin, Cheng-Li Kao, Chia-Hung |
Author_xml | – sequence: 1 givenname: Jung-Chun surname: Lin fullname: Lin, Jung-Chun organization: Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan – sequence: 2 givenname: Chin-Sheng surname: Lin fullname: Lin, Chin-Sheng organization: †Division of Cardiology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan – sequence: 3 givenname: Chin-Wang surname: Hsu fullname: Hsu, Chin-Wang organization: ‡Department of Emergency Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan – sequence: 4 givenname: Cheng-Li surname: Lin fullname: Lin, Cheng-Li organization: ‖Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan – sequence: 5 givenname: Chia-Hung surname: Kao fullname: Kao, Chia-Hung organization: Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26919462$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtPGzEUha2Kivc_qCpLXZTNgD3j-MGOBGgjUVq12VuemTuq6YwdbE-j_HsMIVKVDbUXvpK_c3TvPUdoz3kHCH2g5JwSJS6-zafn5N8jqsk7dEgnFS-YZGwv10TIgiglD9BRjA-ElPmqfXRQckUV4-UhWl_F6BtrkvUOTyGtABz-YcIf66J3nyO-thFMBGxci-eu680wmOTDGk_9Cvrt9yU2-P7FZGVbwAtjV8ZBlv2EFHxcQpPsX8Az_9uHhH-lsV2foPed6SOcvr7HaHF7s5h9Le6-f5nPru6KhhGZCtYISURLGMtDi5Yx2laqlZ3gXWUoN52qFa_Lusk1iDyfrDpFOJgaahBldYzONrbL4B9HiEkPNjbQ97k_P0ZNJZGCUCHE26iQlaKClTKjn3bQBz8Gl-fQFeVKTkpe0kx9fKXGeoBWL4MdTFjr7fozcLkBmrykGKDTjU0va0zB2F5Top-z1jlrvZt1FrMd8db_DdnFRubH5f8pngBDWbhH |
CitedBy_id | crossref_primary_10_1111_eci_12983 crossref_primary_10_1093_ibd_izy190 crossref_primary_10_4103_1673_5374_317981 crossref_primary_10_4103_mgmj_mgmj_296_24 crossref_primary_10_1136_gutjnl_2020_322429 crossref_primary_10_1093_ibd_izae074 crossref_primary_10_1080_19490976_2020_1830694 crossref_primary_10_1136_gutjnl_2018_317103 crossref_primary_10_3389_fimmu_2019_00239 crossref_primary_10_1007_s00415_019_09320_1 crossref_primary_10_3390_ijms23126626 crossref_primary_10_1007_s00441_018_2856_4 crossref_primary_10_3233_JPD_223180 crossref_primary_10_1007_s11910_024_01339_w crossref_primary_10_1002_mdc3_70029 crossref_primary_10_1126_scitranslmed_aai7795 crossref_primary_10_14336_AD_2021_0418 crossref_primary_10_1007_s00401_017_1777_8 crossref_primary_10_1007_s11481_024_10163_5 crossref_primary_10_3389_fneur_2018_00162 crossref_primary_10_1038_s41582_020_0344_4 crossref_primary_10_1016_j_neurobiolaging_2023_07_005 crossref_primary_10_1111_jcmm_17784 crossref_primary_10_1136_gutjnl_2018_316537 crossref_primary_10_1136_gutjnl_2017_315666 crossref_primary_10_1136_gutjnl_2018_316937 crossref_primary_10_3233_JPD_223179 crossref_primary_10_1016_j_cgh_2019_10_006 crossref_primary_10_1001_jamaneurol_2018_0345 crossref_primary_10_1038_s41531_021_00170_1 crossref_primary_10_1111_ene_15711 crossref_primary_10_1038_s41531_022_00318_7 crossref_primary_10_1093_ibd_izz181 crossref_primary_10_1159_000533676 crossref_primary_10_1093_ibd_izae012 crossref_primary_10_3390_life13040897 crossref_primary_10_3233_JPD_230021 crossref_primary_10_1016_S2468_1253_19_30173_6 crossref_primary_10_1097_MCG_0000000000001714 crossref_primary_10_3389_fnagi_2022_919343 crossref_primary_10_1002_mds_27802 crossref_primary_10_1371_journal_pone_0251042 crossref_primary_10_1111_nan_12962 crossref_primary_10_1007_s00415_019_09321_0 crossref_primary_10_1007_s10286_020_00745_7 crossref_primary_10_1038_s41531_016_0002_0 crossref_primary_10_3389_fnins_2019_00839 crossref_primary_10_1007_s13311_020_00942_2 crossref_primary_10_3390_biomedicines10102577 crossref_primary_10_1111_1462_2920_14506 crossref_primary_10_1016_j_nbd_2022_105806 crossref_primary_10_3389_fmed_2022_1014290 crossref_primary_10_1007_s11064_019_02896_0 crossref_primary_10_1007_s00406_022_01389_6 crossref_primary_10_1007_s00401_023_02595_9 crossref_primary_10_1097_FBP_0000000000000389 crossref_primary_10_1016_j_parkreldis_2018_02_008 crossref_primary_10_1007_s10143_021_01516_2 crossref_primary_10_1016_j_je_2016_12_015 crossref_primary_10_3390_ijms22168870 crossref_primary_10_2139_ssrn_4109439 crossref_primary_10_2147_JIR_S337549 crossref_primary_10_3233_JPD_230315 crossref_primary_10_3389_fnagi_2022_955919 crossref_primary_10_1038_s41575_018_0006_9 crossref_primary_10_3389_fnins_2024_1210939 crossref_primary_10_1007_s10620_017_4500_7 crossref_primary_10_3389_fnagi_2022_976316 crossref_primary_10_3390_antiox11010071 crossref_primary_10_3390_jcm9082422 crossref_primary_10_1016_j_ajpath_2021_09_006 crossref_primary_10_1016_j_pnpbp_2024_111203 crossref_primary_10_1111_cns_13916 crossref_primary_10_14802_jmd_18067 crossref_primary_10_1016_j_ymeth_2017_08_001 crossref_primary_10_1136_bmjopen_2017_020821 crossref_primary_10_3390_cells9020376 crossref_primary_10_1001_jamaneurol_2018_0605 crossref_primary_10_5009_gnl220523 crossref_primary_10_12688_f1000research_9699_1 crossref_primary_10_2174_0118715273270874231205050727 crossref_primary_10_4103_AOMD_AOMD_4_18 crossref_primary_10_1016_j_brainresbull_2022_02_015 crossref_primary_10_12688_f1000research_9699_2 crossref_primary_10_1097_YPG_0000000000000255 crossref_primary_10_1002_mds_28119 crossref_primary_10_1186_s40478_021_01240_4 crossref_primary_10_1002_mds_28594 crossref_primary_10_3389_fneur_2019_01245 crossref_primary_10_1186_s12974_024_03145_0 crossref_primary_10_1016_j_parkreldis_2018_09_032 crossref_primary_10_1038_s41531_025_00894_4 crossref_primary_10_3389_fnagi_2023_1294879 crossref_primary_10_1097_MD_0000000000007662 crossref_primary_10_1016_j_nbd_2022_105724 crossref_primary_10_1016_j_neuint_2022_105380 crossref_primary_10_1111_jvim_17288 crossref_primary_10_1016_j_dld_2018_09_017 crossref_primary_10_1007_s10072_025_08114_w crossref_primary_10_1126_scitranslmed_adk3225 crossref_primary_10_3390_jcm8081191 crossref_primary_10_1096_fj_202000414R crossref_primary_10_1016_j_anai_2021_03_001 crossref_primary_10_1093_ecco_jcc_jjab162 crossref_primary_10_1016_j_biopsych_2021_01_002 crossref_primary_10_1186_s12974_021_02317_6 crossref_primary_10_3389_fphar_2021_706439 crossref_primary_10_1038_s41390_019_0702_3 crossref_primary_10_1136_gutjnl_2020_320789 crossref_primary_10_2478_prolas_2022_0094 crossref_primary_10_1111_coa_13647 crossref_primary_10_1002_mds_27326 crossref_primary_10_1111_jgh_15855 crossref_primary_10_3389_fnmol_2019_00218 crossref_primary_10_3390_brainsci12060774 crossref_primary_10_3389_fimmu_2023_1103053 crossref_primary_10_3233_JPD_223568 crossref_primary_10_1016_j_tins_2018_09_007 crossref_primary_10_1007_s40473_017_0129_2 crossref_primary_10_1124_pharmrev_122_000674 crossref_primary_10_1080_00365521_2019_1641739 crossref_primary_10_1038_s41577_022_00684_6 crossref_primary_10_1016_j_nbd_2022_105627 crossref_primary_10_1093_ibd_izab175 crossref_primary_10_1002_mds_28890 crossref_primary_10_1152_ajpgi_00058_2020 crossref_primary_10_1159_000518147 crossref_primary_10_1016_j_parkreldis_2018_06_027 crossref_primary_10_1186_s12929_022_00839_6 crossref_primary_10_1136_bmjopen_2018_025574 crossref_primary_10_17116_jnevro202112110286 crossref_primary_10_3389_fneur_2022_882628 crossref_primary_10_1007_s10096_016_2836_0 crossref_primary_10_1055_s_0043_1771467 crossref_primary_10_1016_j_mehy_2022_110799 crossref_primary_10_1007_s00281_022_00947_3 crossref_primary_10_1038_s41419_024_06670_1 crossref_primary_10_15616_BSL_2018_24_4_334 crossref_primary_10_3233_JPD_191729 crossref_primary_10_1002_mds_28004 crossref_primary_10_3390_biom10091327 |
Cites_doi | 10.1097/01.MIB.0000441200.10454.4f 10.1097/00019052-200008000-00010 10.1053/j.gastro.2011.10.001 10.1385/ENDO:21:1:81 10.1371/journal.pone.0028032 10.1371/journal.pone.0060435 10.1002/ibd.22888 10.1371/journal.pone.0018513 10.1186/1742-2094-9-94 10.1111/liv.12875 10.1007/s00702-011-0653-2 10.1016/j.nbd.2012.09.007 10.1007/s10048-006-0041-5 10.1136/gut.2010.224154 10.1371/journal.pone.0108204 10.1073/pnas.94.14.7531 10.1038/ng.175 10.1111/j.1440-1746.2010.06241.x 10.1038/nri3661 10.1136/gut.42.4.477 10.1074/jbc.M008072200 10.1056/NEJMra0804647 10.1371/journal.pone.0102294 10.4088/JCP.13m08790 10.4049/jimmunol.1000548 10.1186/1744-9081-9-19 10.1016/j.bbi.2013.07.007 10.1016/j.neures.2006.11.012 10.1371/journal.pone.0056944 10.1212/WNL.0b013e3181c06635 10.1016/j.neulet.2005.11.012 10.1016/S0140-6736(14)61393-3 10.1038/35079107 10.1097/MD.0000000000000869 10.1159/000356531 10.1007/s10620-015-3630-z 10.3389/fncel.2013.00053 10.1111/j.1365-2796.2008.01963.x |
ContentType | Journal Article |
Copyright | Copyright © 2016 Crohn's & Colitis Foundation of America, Inc. 2016 Copyright © 2016 Crohn's & Colitis Foundation of America, Inc. |
Copyright_xml | – notice: Copyright © 2016 Crohn's & Colitis Foundation of America, Inc. 2016 – notice: Copyright © 2016 Crohn's & Colitis Foundation of America, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 7T5 H94 |
DOI | 10.1097/MIB.0000000000000735 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts ProQuest One Academic Middle East (New) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-4844 |
EndPage | 1055 |
ExternalDocumentID | 26919462 10_1097_MIB_0000000000000735 10.1097/MIB.0000000000000735 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .Z2 0R~ 1OC 3WU 48X 53G 5GY 5VS 5WD 66C 7O~ 8-0 8UM AAAXR AABZA AACZT AAKAS AAPQZ AAPXW AARHZ AARTV AAUAY AAVAP AAYEP ABBUW ABDFA ABEJV ABGNP ABJNI ABNHQ ABOCM ABPQP ABPTD ABQNK ABVGC ABWST ABXVJ ABXVV ABZAD ACDDN ACEWG ACGFO ACGFS ACUTJ ACWDW ACWRI ACXNZ ACYHN ADBBV ADBIZ ADGZP ADIPN ADQBN ADRTK ADVEK ADZCM AENEX AETBJ AFFZL AFOFC AFTRI AFUWQ AFXAL AGINJ AGQXC AGUTN AHMBA AHMMS AIJEX AIZYK AJEEA ALMA_UNASSIGNED_HOLDINGS ATGXG AWKKM BAYMD BCRHZ BEYMZ BOYCO BTRTY C45 CDBKE CS3 DAKXR DR2 DU5 E.X E3Z EBS EJD ENERS EX3 F5P FECEO FL- FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H0~ HZ~ IN~ IX1 KBUDW KOP KSI KSN LAW MHKGH NNB NOMLY NOYVH NVLIB N~7 N~B O9- OAUYM OCZFY ODMLO OIG OJZSN OPAEJ OVD OWPYF P2P PAFKI PQQKQ QRW ROX RUSNO RX1 S4S TEORI V2E WOW XV2 YAYTL YKOAZ YXANX ZFV 31~ 4.4 7X7 8-1 88E 8F7 8FI 8FJ AAJQQ AAPGJ AAUQX AAWDT AAYXX ABUWG ACFRR ACVCV ACXQS ACZBC ADMTO ADNBA AEMQT AFBPY AFFQV AFKRA AFYAG AFZJQ AGKRT AGMDO AGORE AHGBF AHRYX AJAOE AJBYB AJDVS AJNCP AJNYG ALXQX APJGH AQDSO AQKUS AVNTJ BENPR CCPQU CITATION EIHJH FYUFA H13 HMCUK IAO IHR ITC JXSIZ LH4 LW6 M1P MBLQV NU- OBFPC OCUKA ORVUJ PHGZM PHGZT PSQYO ROL TMA UKHRP W99 WOQ Y6R CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c408t-4c7807d0440977d441d39d8f76f3a16af9b96b2bc16ae702083f906eabebe723 |
IEDL.DBID | 7X7 |
ISSN | 1078-0998 1536-4844 |
IngestDate | Fri Jul 11 05:01:47 EDT 2025 Fri Jul 11 09:26:49 EDT 2025 Fri Jul 25 21:50:34 EDT 2025 Wed Feb 19 02:40:43 EST 2025 Thu Apr 24 22:59:15 EDT 2025 Tue Jul 01 04:19:53 EDT 2025 Sat Feb 08 08:13:05 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | inflammatory bowel disease Parkinson's disease cohort study |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c408t-4c7807d0440977d441d39d8f76f3a16af9b96b2bc16ae702083f906eabebe723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 26919462 |
PQID | 3169852621 |
PQPubID | 996336 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1808701777 proquest_miscellaneous_1783917428 proquest_journals_3169852621 pubmed_primary_26919462 crossref_citationtrail_10_1097_MIB_0000000000000735 crossref_primary_10_1097_MIB_0000000000000735 oup_primary_10_1097_MIB_0000000000000735 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20160501 2016-05-00 2016-May |
PublicationDateYYYYMMDD | 2016-05-01 |
PublicationDate_xml | – month: 05 year: 2016 text: 20160501 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England – name: Baltimore |
PublicationTitle | Inflammatory bowel diseases |
PublicationTitleAlternate | Inflamm Bowel Dis |
PublicationYear | 2016 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Pessoa Rocha (R26-4-20160420) 2014; 21 Chao (R27-4-20160420) 2014; 2014 Lai (R18-4-20160420) 2015; 94 Lawrence (R22-4-20160420) 2014; 9 Devos (R33-4-20160420) 2013; 50 Barrett (R10-4-20160420) 2008; 40 Lindqvist (R25-4-20160420) 2013; 33 Schreiber (R38-4-20160420) 1998; 42 Di Fonzo (R13-4-20160420) 2006; 7 Braak (R30-4-20160420) 2006; 396 Forsyth (R32-4-20160420) 2011; 6 Mowat (R6-4-20160420) 2011; 60 Rugbjerg (R29-4-20160420) 2009; 73 Neurath (R9-4-20160420) 2014; 14 Kalia (R2-4-20160420) 2015; 386 Hakimi (R39-4-20160420) 2011; 118 Tsai (R17-4-20160420) 2014; 20 Abraham (R7-4-20160420) 2009; 361 Leal (R8-4-20160420) 2013; 7 Hugot (R11-4-20160420) 2001; 411 Nahon (R23-4-20160420) 2012; 18 Molodecky (R3-4-20160420) 2012; 142 Tanner (R1-4-20160420) 2000; 13 Hunot (R37-4-20160420) 1997; 94 Greggio (R41-4-20160420) 2012; 9 Guloksuz (R24-4-20160420) 2013; 8 Neunlist (R31-4-20160420) 2008; 263 Ooi (R4-4-20160420) 2010; 25 Bialecka (R12-4-20160420) 2007; 57 Lin (R16-4-20160420) 2016; 36 Gardet (R40-4-20160420) 2010; 185 Kuo (R5-4-20160420) 2015; 60 Ma (R34-4-20160420) 2013; 9 Huang (R19-4-20160420) 2015; 76 Kristensen (R21-4-20160420) 2013; 8 Ogura (R36-4-20160420) 2001; 276 Ballester (R35-4-20160420) 2014; 9 Saunders-Pullman (R20-4-20160420) 2003; 21 Yanamandra (R28-4-20160420) 2011; 6 |
References_xml | – volume: 20 start-page: 502 year: 2014 ident: R17-4-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1097/01.MIB.0000441200.10454.4f – volume: 13 start-page: 427 year: 2000 ident: R1-4-20160420 publication-title: Curr Opin Neurol. doi: 10.1097/00019052-200008000-00010 – volume: 142 start-page: 46 year: 2012 ident: R3-4-20160420 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.10.001 – volume: 21 start-page: 81 year: 2003 ident: R20-4-20160420 publication-title: Endocrine doi: 10.1385/ENDO:21:1:81 – volume: 6 start-page: e28032 year: 2011 ident: R32-4-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0028032 – volume: 8 start-page: e60435 year: 2013 ident: R24-4-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0060435 – volume: 18 start-page: 2086 year: 2012 ident: R23-4-20160420 publication-title: Inflamm Bowel Dis. doi: 10.1002/ibd.22888 – volume: 6 start-page: e18513 year: 2011 ident: R28-4-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0018513 – volume: 9 start-page: 94 year: 2012 ident: R41-4-20160420 publication-title: J Neuroinflammation. doi: 10.1186/1742-2094-9-94 – volume: 36 start-page: 136 year: 2016 ident: R16-4-20160420 publication-title: Liver Int. doi: 10.1111/liv.12875 – volume: 2014 start-page: 308654 year: 2014 ident: R27-4-20160420 publication-title: Biomed Res Int. – volume: 118 start-page: 795 year: 2011 ident: R39-4-20160420 publication-title: J Neural Transm (Vienna). doi: 10.1007/s00702-011-0653-2 – volume: 50 start-page: 42 year: 2013 ident: R33-4-20160420 publication-title: Neurobiol Dis. doi: 10.1016/j.nbd.2012.09.007 – volume: 7 start-page: 133 year: 2006 ident: R13-4-20160420 publication-title: Neurogenetics doi: 10.1007/s10048-006-0041-5 – volume: 60 start-page: 571 year: 2011 ident: R6-4-20160420 publication-title: Gut doi: 10.1136/gut.2010.224154 – volume: 9 start-page: e108204 year: 2014 ident: R35-4-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0108204 – volume: 94 start-page: 7531 year: 1997 ident: R37-4-20160420 publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.94.14.7531 – volume: 40 start-page: 955 year: 2008 ident: R10-4-20160420 publication-title: Nat Genet. doi: 10.1038/ng.175 – volume: 25 start-page: 453 year: 2010 ident: R4-4-20160420 publication-title: J Gastroenterol Hepatol. doi: 10.1111/j.1440-1746.2010.06241.x – volume: 14 start-page: 329 year: 2014 ident: R9-4-20160420 publication-title: Nat Rev Immunol. doi: 10.1038/nri3661 – volume: 42 start-page: 477 year: 1998 ident: R38-4-20160420 publication-title: Gut doi: 10.1136/gut.42.4.477 – volume: 276 start-page: 4812 year: 2001 ident: R36-4-20160420 publication-title: J Biol Chem. doi: 10.1074/jbc.M008072200 – volume: 361 start-page: 2066 year: 2009 ident: R7-4-20160420 publication-title: N Engl J Med. doi: 10.1056/NEJMra0804647 – volume: 9 start-page: e102294 year: 2014 ident: R22-4-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0102294 – volume: 76 start-page: e104 year: 2015 ident: R19-4-20160420 publication-title: J Clin Psychiatry. doi: 10.4088/JCP.13m08790 – volume: 185 start-page: 5577 year: 2010 ident: R40-4-20160420 publication-title: J Immunol. doi: 10.4049/jimmunol.1000548 – volume: 9 start-page: 19 year: 2013 ident: R34-4-20160420 publication-title: Behav Brain Funct. doi: 10.1186/1744-9081-9-19 – volume: 33 start-page: 183 year: 2013 ident: R25-4-20160420 publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2013.07.007 – volume: 57 start-page: 473 year: 2007 ident: R12-4-20160420 publication-title: Neurosci Res. doi: 10.1016/j.neures.2006.11.012 – volume: 8 start-page: e56944 year: 2013 ident: R21-4-20160420 publication-title: PLoS One doi: 10.1371/journal.pone.0056944 – volume: 73 start-page: 1462 year: 2009 ident: R29-4-20160420 publication-title: Neurology doi: 10.1212/WNL.0b013e3181c06635 – volume: 396 start-page: 67 year: 2006 ident: R30-4-20160420 publication-title: Neurosci Lett. doi: 10.1016/j.neulet.2005.11.012 – volume: 386 start-page: 896 year: 2015 ident: R2-4-20160420 publication-title: Lancet doi: 10.1016/S0140-6736(14)61393-3 – volume: 411 start-page: 599 year: 2001 ident: R11-4-20160420 publication-title: Nature doi: 10.1038/35079107 – volume: 94 start-page: e869 year: 2015 ident: R18-4-20160420 publication-title: Medicine (Baltimore). doi: 10.1097/MD.0000000000000869 – volume: 21 start-page: 88 year: 2014 ident: R26-4-20160420 publication-title: Neuroimmunomodulation doi: 10.1159/000356531 – volume: 60 start-page: 2454 year: 2015 ident: R5-4-20160420 publication-title: Dig Dis Sci. doi: 10.1007/s10620-015-3630-z – volume: 7 start-page: 53 year: 2013 ident: R8-4-20160420 publication-title: Front Cell Neurosci. doi: 10.3389/fncel.2013.00053 – volume: 263 start-page: 577 year: 2008 ident: R31-4-20160420 publication-title: J Intern Med. doi: 10.1111/j.1365-2796.2008.01963.x |
SSID | ssj0020209 |
Score | 2.5349774 |
Snippet | ObjectivesInflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the... Inflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases the risk of... Objectives: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder. Previous studies have suggested that chronic systemic inflammation increases... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1049 |
SubjectTerms | Adult Aged Cardiovascular disease Comorbidity Female Follow-Up Studies Humans Incidence Inflammatory bowel disease Inflammatory Bowel Diseases - complications Male Middle Aged Parkinson Disease - epidemiology Parkinson Disease - etiology Parkinson's disease Prognosis Retrospective Studies Risk Factors Taiwan - epidemiology |
Title | Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26919462 https://www.proquest.com/docview/3169852621 https://www.proquest.com/docview/1783917428 https://www.proquest.com/docview/1808701777 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS-QwEB88heNexPte9STCwd1LsE27k8QXcf1AD1aOZQ_2raRpygnaqruy-N87adrduxP0-tSSFEJmMvkl8_ED-Cpjp0utLNe0n3DaIRxXyuQchXACtZN97bORhxd49iv9MelP2gu3aRtW2dnExlAXtfV35HtJjFr1BYr44OaWe9Yo711tKTRewZovXeZDuuRkeeCKQogHnXC8i1-rLnVOy73h-SCULuwe2RC-Lbemv9LdnqDOZvc53YD1FjaywyDnt7Diqnfwetg6xt_Dwx_TzAYh9or5jOYmuevblB0HRwwzVcHOq5L04Lrxr7NBPXdXXfM-MyxUyp5fFo6NzeXceIpKNnKzu7rLymRH9W9C7czHID58gPHpyfjojLesCtymkZrx1EoVycJTTRP2KwgOFYkuVCmxTEyMptS5xlzklt6d9ByeSakjdCYneUuRfITVqq7cZ2C5iUu0JnVobdoQAyJaiZYMbFRagT1IuvnMbFtx3BNfXGWd55ukkP0rhR7wxV83oeLGC_2_k6j-s-t2J8-sXarTbKlYPdhdNNMi854TmuP6fprFknAknd2EeqaPisj2xVLKHnwKurIYFGl9rFMUm88PYAveEB7DEE-5Dauzu3v3hTDPLN9pFHsH1gYnFz9H9HU8Eo-9OPo3 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFD6UFLq9jK27ZetWDTa2F1FbdnQplLH0QrI2YZQM-mZkWWaFzu6alJAftf-4I8tK1xXavdRPBskg6xydi87lA3gvYqtKJQ1VqE8oaghLpdQ55YxZxpUVPeWqkUdjPviefj3pnazA71AL49Iqg0xsBHVRG3dHvpXEXMke4yz-fP6LOtQoF10NEBqeLQ7tYo4u23RnuIf0_cDYwf5kd0BbVAFq0kjOaGqEjEThoJbR9inQHCgSVchS8DLRMdelyhXPWW7w3QqHYZmUKuJW5_i_wvU5QIm_miboyXRgtb8__na89PAin1OCLpXLKVAy1OopsTUa9n2vxPCIBmHuShdeq6-7YeY26u7gMTxq7VTyxTPWE1ix1TqsjdpI_FNY_EVX0vfJXsSVUDfVZB-nZM9HfoiuCjKsSmS8n01An_TruT0Lw9tEE9-ae35aWDLRp3PtMDHJsZ1d1KEMlOzWP9BNIC7pcfEMJvex4c-hU9WVfQkk13HJjU4tNyZtkAg5N4IblOhRaRjvQhL2MzNti3OHtHGWhVA7UiH7lwpdoMuvzn2Ljzvmf0JS_efUjUDPrJUN0-yKk7vwbjmMp9qFanCP68tpFgs0XNFZZPKWOTJCYRsLIbrwwvPKclF4zGKVcvbq9gVswoPBZHSUHQ3Hh6_hIRqD3CdzbkBndnFp36DBNcvftmxOILvng_UHVLs1EA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+Between+Parkinson%27s+Disease+and+Inflammatory+Bowel+Disease%3A+a+Nationwide+Taiwanese+Retrospective+Cohort+Study&rft.jtitle=Inflammatory+bowel+diseases&rft.au=Lin%2C+Jung-Chun&rft.au=Lin%2C+Chin-Sheng&rft.au=Hsu%2C+Chin-Wang&rft.au=Lin%2C+Cheng-Li&rft.date=2016-05-01&rft.issn=1078-0998&rft.eissn=1536-4844&rft.volume=22&rft.issue=5&rft.spage=1049&rft.epage=1055&rft_id=info:doi/10.1097%2FMIB.0000000000000735&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0998&client=summon |